Blood Plasma Derivatives Market - Global Outlook and Forecast 2022-2028

January 2022 | 113 pages | ID: BD1144AA76F5EN
Market Monitor Global

Abstracts

Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.

This report contains market size and forecasts of Blood Plasma Derivatives in Global, including the following market information:

Global Blood Plasma Derivatives Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Blood Plasma Derivatives market was valued at 31790 million in 2021 and is projected to reach US$ 46100 million by 2028, at a CAGR of 5.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Albumin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Blood Plasma Derivatives include Grifols, SK Plasma, Fusion Health Care, Biotest AG, Green Cross Corporation, Baxter International, LFB, Octapharma AG and CSL Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Blood Plasma Derivatives companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Blood Plasma Derivatives Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Blood Plasma Derivatives Market Segment Percentages, by Type, 2021 (%)

• Albumin
• Factor VIII
• Factor IX
• Immunoglobulin
• Hyperimmune Globulin
• Others

Global Blood Plasma Derivatives Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Blood Plasma Derivatives Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Other End Users

Global Blood Plasma Derivatives Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Blood Plasma Derivatives Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Blood Plasma Derivatives revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Blood Plasma Derivatives revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Grifols
• SK Plasma
• Fusion Health Care
• Biotest AG
• Green Cross Corporation
• Baxter International
• LFB
• Octapharma AG
• CSL Limited
• Takeda
• China Biologic Products
• Kedrion Biopharma
• BDI Pharma
• Bayer AG
• Hualan Biological Engineering

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Blood Plasma Derivatives Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Blood Plasma Derivatives Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BLOOD PLASMA DERIVATIVES OVERALL MARKET SIZE

2.1 Global Blood Plasma Derivatives Market Size: 2021 VS 2028
2.2 Global Blood Plasma Derivatives Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Blood Plasma Derivatives Players in Global Market
3.2 Top Global Blood Plasma Derivatives Companies Ranked by Revenue
3.3 Global Blood Plasma Derivatives Revenue by Companies
3.4 Top 3 and Top 5 Blood Plasma Derivatives Companies in Global Market, by Revenue in 2021
3.5 Global Companies Blood Plasma Derivatives Product Type
3.6 Tier 1, Tier 2 and Tier 3 Blood Plasma Derivatives Players in Global Market
  3.6.1 List of Global Tier 1 Blood Plasma Derivatives Companies
  3.6.2 List of Global Tier 2 and Tier 3 Blood Plasma Derivatives Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Blood Plasma Derivatives Market Size Markets, 2021 & 2028
  4.1.2 Albumin
  4.1.3 Factor VIII
  4.1.4 Factor IX
  4.1.5 Immunoglobulin
  4.1.6 Hyperimmune Globulin
  4.1.7 Others
4.2 By Type - Global Blood Plasma Derivatives Revenue & Forecasts
  4.2.1 By Type - Global Blood Plasma Derivatives Revenue, 2017-2022
  4.2.2 By Type - Global Blood Plasma Derivatives Revenue, 2023-2028
  4.2.3 By Type - Global Blood Plasma Derivatives Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Blood Plasma Derivatives Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Other End Users
5.2 By Application - Global Blood Plasma Derivatives Revenue & Forecasts
  5.2.1 By Application - Global Blood Plasma Derivatives Revenue, 2017-2022
  5.2.2 By Application - Global Blood Plasma Derivatives Revenue, 2023-2028
  5.2.3 By Application - Global Blood Plasma Derivatives Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Blood Plasma Derivatives Market Size, 2021 & 2028
6.2 By Region - Global Blood Plasma Derivatives Revenue & Forecasts
  6.2.1 By Region - Global Blood Plasma Derivatives Revenue, 2017-2022
  6.2.2 By Region - Global Blood Plasma Derivatives Revenue, 2023-2028
  6.2.3 By Region - Global Blood Plasma Derivatives Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Blood Plasma Derivatives Revenue, 2017-2028
  6.3.2 US Blood Plasma Derivatives Market Size, 2017-2028
  6.3.3 Canada Blood Plasma Derivatives Market Size, 2017-2028
  6.3.4 Mexico Blood Plasma Derivatives Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Blood Plasma Derivatives Revenue, 2017-2028
  6.4.2 Germany Blood Plasma Derivatives Market Size, 2017-2028
  6.4.3 France Blood Plasma Derivatives Market Size, 2017-2028
  6.4.4 U.K. Blood Plasma Derivatives Market Size, 2017-2028
  6.4.5 Italy Blood Plasma Derivatives Market Size, 2017-2028
  6.4.6 Russia Blood Plasma Derivatives Market Size, 2017-2028
  6.4.7 Nordic Countries Blood Plasma Derivatives Market Size, 2017-2028
  6.4.8 Benelux Blood Plasma Derivatives Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Blood Plasma Derivatives Revenue, 2017-2028
  6.5.2 China Blood Plasma Derivatives Market Size, 2017-2028
  6.5.3 Japan Blood Plasma Derivatives Market Size, 2017-2028
  6.5.4 South Korea Blood Plasma Derivatives Market Size, 2017-2028
  6.5.5 Southeast Asia Blood Plasma Derivatives Market Size, 2017-2028
  6.5.6 India Blood Plasma Derivatives Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Blood Plasma Derivatives Revenue, 2017-2028
  6.6.2 Brazil Blood Plasma Derivatives Market Size, 2017-2028
  6.6.3 Argentina Blood Plasma Derivatives Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Blood Plasma Derivatives Revenue, 2017-2028
  6.7.2 Turkey Blood Plasma Derivatives Market Size, 2017-2028
  6.7.3 Israel Blood Plasma Derivatives Market Size, 2017-2028
  6.7.4 Saudi Arabia Blood Plasma Derivatives Market Size, 2017-2028
  6.7.5 UAE Blood Plasma Derivatives Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Grifols
  7.1.1 Grifols Corporate Summary
  7.1.2 Grifols Business Overview
  7.1.3 Grifols Blood Plasma Derivatives Major Product Offerings
  7.1.4 Grifols Blood Plasma Derivatives Revenue in Global Market (2017-2022)
  7.1.5 Grifols Key News
7.2 SK Plasma
  7.2.1 SK Plasma Corporate Summary
  7.2.2 SK Plasma Business Overview
  7.2.3 SK Plasma Blood Plasma Derivatives Major Product Offerings
  7.2.4 SK Plasma Blood Plasma Derivatives Revenue in Global Market (2017-2022)
  7.2.5 SK Plasma Key News
7.3 Fusion Health Care
  7.3.1 Fusion Health Care Corporate Summary
  7.3.2 Fusion Health Care Business Overview
  7.3.3 Fusion Health Care Blood Plasma Derivatives Major Product Offerings
  7.3.4 Fusion Health Care Blood Plasma Derivatives Revenue in Global Market (2017-2022)
  7.3.5 Fusion Health Care Key News
7.4 Biotest AG
  7.4.1 Biotest AG Corporate Summary
  7.4.2 Biotest AG Business Overview
  7.4.3 Biotest AG Blood Plasma Derivatives Major Product Offerings
  7.4.4 Biotest AG Blood Plasma Derivatives Revenue in Global Market (2017-2022)
  7.4.5 Biotest AG Key News
7.5 Green Cross Corporation
  7.5.1 Green Cross Corporation Corporate Summary
  7.5.2 Green Cross Corporation Business Overview
  7.5.3 Green Cross Corporation Blood Plasma Derivatives Major Product Offerings
  7.5.4 Green Cross Corporation Blood Plasma Derivatives Revenue in Global Market (2017-2022)
  7.5.5 Green Cross Corporation Key News
7.6 Baxter International
  7.6.1 Baxter International Corporate Summary
  7.6.2 Baxter International Business Overview
  7.6.3 Baxter International Blood Plasma Derivatives Major Product Offerings
  7.6.4 Baxter International Blood Plasma Derivatives Revenue in Global Market (2017-2022)
  7.6.5 Baxter International Key News
7.7 LFB
  7.7.1 LFB Corporate Summary
  7.7.2 LFB Business Overview
  7.7.3 LFB Blood Plasma Derivatives Major Product Offerings
  7.7.4 LFB Blood Plasma Derivatives Revenue in Global Market (2017-2022)
  7.7.5 LFB Key News
7.8 Octapharma AG
  7.8.1 Octapharma AG Corporate Summary
  7.8.2 Octapharma AG Business Overview
  7.8.3 Octapharma AG Blood Plasma Derivatives Major Product Offerings
  7.8.4 Octapharma AG Blood Plasma Derivatives Revenue in Global Market (2017-2022)
  7.8.5 Octapharma AG Key News
7.9 CSL Limited
  7.9.1 CSL Limited Corporate Summary
  7.9.2 CSL Limited Business Overview
  7.9.3 CSL Limited Blood Plasma Derivatives Major Product Offerings
  7.9.4 CSL Limited Blood Plasma Derivatives Revenue in Global Market (2017-2022)
  7.9.5 CSL Limited Key News
7.10 Takeda
  7.10.1 Takeda Corporate Summary
  7.10.2 Takeda Business Overview
  7.10.3 Takeda Blood Plasma Derivatives Major Product Offerings
  7.10.4 Takeda Blood Plasma Derivatives Revenue in Global Market (2017-2022)
  7.10.5 Takeda Key News
7.11 China Biologic Products
  7.11.1 China Biologic Products Corporate Summary
  7.11.2 China Biologic Products Business Overview
  7.11.3 China Biologic Products Blood Plasma Derivatives Major Product Offerings
  7.11.4 China Biologic Products Blood Plasma Derivatives Revenue in Global Market (2017-2022)
  7.11.5 China Biologic Products Key News
7.12 Kedrion Biopharma
  7.12.1 Kedrion Biopharma Corporate Summary
  7.12.2 Kedrion Biopharma Business Overview
  7.12.3 Kedrion Biopharma Blood Plasma Derivatives Major Product Offerings
  7.12.4 Kedrion Biopharma Blood Plasma Derivatives Revenue in Global Market (2017-2022)
  7.12.5 Kedrion Biopharma Key News
7.13 BDI Pharma
  7.13.1 BDI Pharma Corporate Summary
  7.13.2 BDI Pharma Business Overview
  7.13.3 BDI Pharma Blood Plasma Derivatives Major Product Offerings
  7.13.4 BDI Pharma Blood Plasma Derivatives Revenue in Global Market (2017-2022)
  7.13.5 BDI Pharma Key News
7.14 Bayer AG
  7.14.1 Bayer AG Corporate Summary
  7.14.2 Bayer AG Business Overview
  7.14.3 Bayer AG Blood Plasma Derivatives Major Product Offerings
  7.14.4 Bayer AG Blood Plasma Derivatives Revenue in Global Market (2017-2022)
  7.14.5 Bayer AG Key News
7.15 Hualan Biological Engineering
  7.15.1 Hualan Biological Engineering Corporate Summary
  7.15.2 Hualan Biological Engineering Business Overview
  7.15.3 Hualan Biological Engineering Blood Plasma Derivatives Major Product Offerings
  7.15.4 Hualan Biological Engineering Blood Plasma Derivatives Revenue in Global Market (2017-2022)
  7.15.5 Hualan Biological Engineering Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Blood Plasma Derivatives Market Opportunities & Trends in Global Market
Table 2. Blood Plasma Derivatives Market Drivers in Global Market
Table 3. Blood Plasma Derivatives Market Restraints in Global Market
Table 4. Key Players of Blood Plasma Derivatives in Global Market
Table 5. Top Blood Plasma Derivatives Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Blood Plasma Derivatives Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Blood Plasma Derivatives Revenue Share by Companies, 2017-2022
Table 8. Global Companies Blood Plasma Derivatives Product Type
Table 9. List of Global Tier 1 Blood Plasma Derivatives Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Blood Plasma Derivatives Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Blood Plasma Derivatives Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Blood Plasma Derivatives Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Blood Plasma Derivatives Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Blood Plasma Derivatives Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Blood Plasma Derivatives Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Blood Plasma Derivatives Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Blood Plasma Derivatives Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Blood Plasma Derivatives Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Blood Plasma Derivatives Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Blood Plasma Derivatives Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Blood Plasma Derivatives Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Blood Plasma Derivatives Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Blood Plasma Derivatives Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Blood Plasma Derivatives Revenue, (US$, Mn), 2023-2028
Table 30. Grifols Corporate Summary
Table 31. Grifols Blood Plasma Derivatives Product Offerings
Table 32. Grifols Blood Plasma Derivatives Revenue (US$, Mn), (2017-2022)
Table 33. SK Plasma Corporate Summary
Table 34. SK Plasma Blood Plasma Derivatives Product Offerings
Table 35. SK Plasma Blood Plasma Derivatives Revenue (US$, Mn), (2017-2022)
Table 36. Fusion Health Care Corporate Summary
Table 37. Fusion Health Care Blood Plasma Derivatives Product Offerings
Table 38. Fusion Health Care Blood Plasma Derivatives Revenue (US$, Mn), (2017-2022)
Table 39. Biotest AG Corporate Summary
Table 40. Biotest AG Blood Plasma Derivatives Product Offerings
Table 41. Biotest AG Blood Plasma Derivatives Revenue (US$, Mn), (2017-2022)
Table 42. Green Cross Corporation Corporate Summary
Table 43. Green Cross Corporation Blood Plasma Derivatives Product Offerings
Table 44. Green Cross Corporation Blood Plasma Derivatives Revenue (US$, Mn), (2017-2022)
Table 45. Baxter International Corporate Summary
Table 46. Baxter International Blood Plasma Derivatives Product Offerings
Table 47. Baxter International Blood Plasma Derivatives Revenue (US$, Mn), (2017-2022)
Table 48. LFB Corporate Summary
Table 49. LFB Blood Plasma Derivatives Product Offerings
Table 50. LFB Blood Plasma Derivatives Revenue (US$, Mn), (2017-2022)
Table 51. Octapharma AG Corporate Summary
Table 52. Octapharma AG Blood Plasma Derivatives Product Offerings
Table 53. Octapharma AG Blood Plasma Derivatives Revenue (US$, Mn), (2017-2022)
Table 54. CSL Limited Corporate Summary
Table 55. CSL Limited Blood Plasma Derivatives Product Offerings
Table 56. CSL Limited Blood Plasma Derivatives Revenue (US$, Mn), (2017-2022)
Table 57. Takeda Corporate Summary
Table 58. Takeda Blood Plasma Derivatives Product Offerings
Table 59. Takeda Blood Plasma Derivatives Revenue (US$, Mn), (2017-2022)
Table 60. China Biologic Products Corporate Summary
Table 61. China Biologic Products Blood Plasma Derivatives Product Offerings
Table 62. China Biologic Products Blood Plasma Derivatives Revenue (US$, Mn), (2017-2022)
Table 63. Kedrion Biopharma Corporate Summary
Table 64. Kedrion Biopharma Blood Plasma Derivatives Product Offerings
Table 65. Kedrion Biopharma Blood Plasma Derivatives Revenue (US$, Mn), (2017-2022)
Table 66. BDI Pharma Corporate Summary
Table 67. BDI Pharma Blood Plasma Derivatives Product Offerings
Table 68. BDI Pharma Blood Plasma Derivatives Revenue (US$, Mn), (2017-2022)
Table 69. Bayer AG Corporate Summary
Table 70. Bayer AG Blood Plasma Derivatives Product Offerings
Table 71. Bayer AG Blood Plasma Derivatives Revenue (US$, Mn), (2017-2022)
Table 72. Hualan Biological Engineering Corporate Summary
Table 73. Hualan Biological Engineering Blood Plasma Derivatives Product Offerings
Table 74. Hualan Biological Engineering Blood Plasma Derivatives Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Blood Plasma Derivatives Segment by Type in 2021
Figure 2. Blood Plasma Derivatives Segment by Application in 2021
Figure 3. Global Blood Plasma Derivatives Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Blood Plasma Derivatives Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Blood Plasma Derivatives Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Blood Plasma Derivatives Revenue in 2021
Figure 8. By Type - Global Blood Plasma Derivatives Revenue Market Share, 2017-2028
Figure 9. By Application - Global Blood Plasma Derivatives Revenue Market Share, 2017-2028
Figure 10. By Region - Global Blood Plasma Derivatives Revenue Market Share, 2017-2028
Figure 11. By Country - North America Blood Plasma Derivatives Revenue Market Share, 2017-2028
Figure 12. US Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Blood Plasma Derivatives Revenue Market Share, 2017-2028
Figure 16. Germany Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 17. France Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Blood Plasma Derivatives Revenue Market Share, 2017-2028
Figure 24. China Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 28. India Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Blood Plasma Derivatives Revenue Market Share, 2017-2028
Figure 30. Brazil Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Blood Plasma Derivatives Revenue Market Share, 2017-2028
Figure 33. Turkey Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Blood Plasma Derivatives Revenue, (US$, Mn), 2017-2028
Figure 37. Grifols Blood Plasma Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. SK Plasma Blood Plasma Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Fusion Health Care Blood Plasma Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Biotest AG Blood Plasma Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Green Cross Corporation Blood Plasma Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Baxter International Blood Plasma Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. LFB Blood Plasma Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Octapharma AG Blood Plasma Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. CSL Limited Blood Plasma Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Takeda Blood Plasma Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. China Biologic Products Blood Plasma Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Kedrion Biopharma Blood Plasma Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. BDI Pharma Blood Plasma Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Bayer AG Blood Plasma Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Hualan Biological Engineering Blood Plasma Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)